Search research articles
Contact Us
Filters
Showing results (251-260 of 483) with videos related to
Page
of 49
Sort By:
Cancer Research
|
November 3, 2012
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility
Tamara Girbl, Elisabeth Hinterseer, Eva Melanie Grössinger, et al.
Journal of Clinical Medicine
|
June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.
British Journal of Cancer
|
October 21, 2016
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients
Katharina T Prochazka, Thomas Melchardt, Florian Posch, et al.
Wiener Klinische Wochenschrift
|
September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.
Phytochemistry
|
June 17, 2019
Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae)
Oleksandr Shulha, Serhat Sezai Çiçek, Helle Wangensteen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy
Martin Filipits, Margaretha Rudas, Harald Heinzl, et al.
European Journal of Haematology
|
February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM
Florian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Anticancer Research
|
January 1, 2015
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial
Magdalena Pircher, Brigitte Mlineritsch, Michael A Fridrik, et al.
Frontiers in Immunology
|
September 29, 2025
Impact of <i>Fusobacterium nucleatum</i> on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort study
Ronald Heregger, Florian Huemer, Richard Greil, et al.
BMC Cancer
|
January 11, 2022
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
Verena Schlintl, Florian Huemer, Gabriel Rinnerthaler, et al.
Page
of 49
Search research articles
Search
Showing results (251-260 of 483) with videos related to
Sort By:
Page
of 49
Cancer Research
|
November 3, 2012
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility
Tamara Girbl, Elisabeth Hinterseer, Eva Melanie Grössinger, et al.
Journal of Clinical Medicine
|
June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.
British Journal of Cancer
|
October 21, 2016
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients
Katharina T Prochazka, Thomas Melchardt, Florian Posch, et al.
Wiener Klinische Wochenschrift
|
September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.
Phytochemistry
|
June 17, 2019
Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae)
Oleksandr Shulha, Serhat Sezai Çiçek, Helle Wangensteen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy
Martin Filipits, Margaretha Rudas, Harald Heinzl, et al.
European Journal of Haematology
|
February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM
Florian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Anticancer Research
|
January 1, 2015
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial
Magdalena Pircher, Brigitte Mlineritsch, Michael A Fridrik, et al.
Frontiers in Immunology
|
September 29, 2025
Impact of <i>Fusobacterium nucleatum</i> on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort study
Ronald Heregger, Florian Huemer, Richard Greil, et al.
BMC Cancer
|
January 11, 2022
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
Verena Schlintl, Florian Huemer, Gabriel Rinnerthaler, et al.
Page
of 49